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Abstract
We integrated biological experimental data with mathematical modelling to gain insights into the role played by L-alanine
in amino acid-stimulated insulin secretion (AASIS) and in D-glucose-stimulated insulin secretion (GSIS), details important to
the understanding of complex b-cell metabolic coupling relationships. We present an ordinary differential equations (ODEs)
based simplified kinetic model of core metabolic processes leading to ATP production (glycolysis, TCA cycle, L-alanine-
specific reactions, respiratory chain, ATPase and proton leak) and Ca2+ handling (essential channels and pumps in the
plasma membrane) in pancreatic b-cells and relate these to insulin secretion. Experimental work was performed using a
clonal rat insulin-secreting cell line (BRIN-BD11) to measure the consumption or production of a range of important
biochemical parameters (D-glucose, L-alanine, ATP, insulin secretion) and Ca2+ levels. These measurements were then used
to validate the theoretical model and fine-tune the parameters. Mathematical modelling was used to predict L-lactate and L-
glutamate concentrations following D-glucose and/or L-alanine challenge and Ca2+ levels upon stimulation with a non
metabolizable L-alanine analogue. Experimental data and mathematical model simulations combined suggest that L-alanine
produces a potent insulinotropic effect via both a stimulatory impact on b-cell metabolism and as a direct result of the
membrane depolarization due to Ca2+ influx triggered by L-alanine/Na+ co-transport. Our simulations indicate that both
high intracellular ATP and Ca2+ concentrations are required in order to develop full insulin secretory responses. The model
confirmed that K+ATP channel independent mechanisms of stimulation of intracellular Ca
2+ levels, via generation of
mitochondrial coupling messengers, are essential for promotion of the full and sustained insulin secretion response in b-
cells.
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Introduction
Pancreatic b-cells have been the subject of both experimental
and theoretical interest for several decades as they play a key role
in D-glucose homeostasis by adjusting insulin secretion according
to blood D-glucose and other nutrients, endocrine and autocrine
secretagogues [1,2]. Insulin release is tightly controlled through
complex metabolic and signal transduction relationships in the b-
cell. An understanding of the biochemical mechanisms underlying
stimulus-secretion coupling in the b-cell is of importance in
determining normal and pathogenic (dys)-regulation of insulin
secretion in diabetes.
The current hypothesis of the mechanism of D-glucose-
stimulated insulin secretion (GSIS) is that D-glucose enters the
b-cell via a membrane-bound D-glucose transporter (GLUT1 or
GLUT2) where it is metabolized in the pathway of glycolysis,
resulting in pyruvate, which can then enter the mitochondria.
Pyruvate is oxidized through the Tricarboxylic Acid (TCA) cycle
producing reducing equivalents (NADH and FADH2) that are
transferred to the mitochondrial electron transport chain (ETC),
resulting in ATP generation. The rise in the ATP/ADP ratio
closes the ATP-sensitive K+-channels (K+ATP) in the cell mem-
brane leading to depolarization, influx of extracellular Ca2+
through the voltage-dependent Ca2+ (Ca2+DY) channels and
mobilization of the insulin-containing vesicles causing their fusion
with the plasma membrane and release of their cargo [3].
Although the K+ ATP–dependent pathway constitutes the main
trigger for insulin exocytosis, metabolic coupling factors generated
by mitochondrial metabolism, such as nucleotides (ATP, GTP,
cAMP, NADPH) and metabolites (malonyl-CoA, citrate, L-
glutamate), can markedly affect the full development of insulin
secretion [1,3,4].
Amino acids represent a significant class of insulin secretion
modulators as they are obtained from dietary proteins as well as
being released by intestinal epithelial cells [2]. Pancreatic b-cells
express a range of specific amino acid transporters, such as systems
A, ASC and L – many of which are Na+-dependent [5–8],
allowing amino acids to be rapidly taken up by b-cells. A mixture
of physiologic concentrations of amino acids (0.1–0.2 mmol/l) or
high concentrations of single amino acids (10–20 mmol/l) have
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been shown to acutely and chronically modulate insulin secretion
both in vitro and in vivo [7]. It is believed that amino acids may
induce insulin secretion by (i) a direct depolarization of the plasma
membrane via transport of positively charged amino acids (e.g L-
arginine) [7,9,10], (ii) metabolism through both triggering and
amplifying pathways linked to the TCA cycle (L-glutamine, L-
leucine and L-alanine) [3,5–8,10-16] and (iii) depolarization of the
plasma membrane induced by Na+ co-transport (L-alanine and L-
proline) [10,17,18].
The amino acid L-alanine is one of the most abundant amino
acids in plasma (0.5–0.7 mmol/l) [7] in physiological conditions
and alterations in its levels, which are indeed found in blood and
urine of type two diabetic patients [19–21], may significantly affect
insulin release.
A number of mathematical and computational models of the
GSIS have been developed, although none of them has taken
AASIS into account. In particular, modelling efforts have been
focussed on the time dependent oscillatory behaviour of the insulin
secretion, both of mitochondrial and electrical origin, which are
lost in type two diabetes [22–24].
Magnus and Keizer built the first combined model of
metabolism and Ca2+ handling in b-cells focussed on describing
the mechanism underlying oscillations rather than the regulatory
properties of the network [25–27]. The model couples Ca2+
handling by the mitochondria with metabolism through ADP and
membrane potential. It takes into account transport processes of
the inner mitochondrial membrane (redox proton pump, F1F0-
ATPase, proton leak ATP/ADP anti-translocation), the Ca2+
uniporter and Na+/Ca2+ exchanger. A simplified model of GSIS,
constituted by four ordinary differential equations for NADH,
ADP, membrane potential and Ca2+ with pyruvate as input and
ATP production as output, has been developed [28] on the basis of
the earlier models of Magnus and Keizer. It investigates the effects
of Ca2+ influx and glycolytic flux on the dynamics of the system
and was able to capture the most noticeable features of the
Magnus and Keizer model, using a simplified mathematical
description. More recently, Fridlyand and co-workers [29]
proposed an integrated kinetic model for D-glucose sensing which
includes the dynamical description of ADP, NADH, glyceralde-
hyde 3-phosphate, membrane potential, NADH, Ca2+ and
pyruvate. The model has been used to investigate the biochemical
regulation and control of b-cells, such as alteration of the proton
leak activity, NADH shuttles function and reactive oxygen species
production.
Since the GSIS machinery is highly complex, mathematical
models have also been developed separately for specific sections of
the pathway such as metabolism and electrophysiology.
Early stage models of mitochondrial energy metabolism include
the work of Garfinkel [30] and Bohnensack [31]. A more detailed
model of general mitochondrial metabolism (e.g. non pancreatic b-
cell specific) including the respiratory chain, the TCA cycle, fatty
acid b-oxidation and the inner membrane transport system,
consisting of 58 enzymatic reactions, 117 metabolites and 5
compartments, was assembled using enzymatic kinetic data from
different animal sources [32]. This model was integrated with a
glycolytic model developed for yeast [33] and constituted the basis
for a very complex and detailed kinetic model of metabolic
processes in pancreatic b-cell made up of 44 enzymatic reactions,
59 metabolic state variables and 272 parameters [34]. This model
could reproduce oscillations in glycolytic metabolites and predict a
dose-response curve for ATP for increasing concentrations of D-
glucose. Other pancreatic b-cell-specific models have been
developed for specific parts of the pathway, such as NADH
shuttles [35] and the initial section of glycolysis [35,36]. This
glycolytic model underlines the dependency of the occurrence of
oscillations as a function of glucokinase, aldolase, phosphofructo-
kinase and GAPD activities. Other detailed models for TCA cycle
[37] and oxidative phosphorylation [38] in specific tissues such as
heart, muscle and liver have previously been developed. In these
models the number of equations and parameters necessary to
describe the dynamic of the system is very high and this may
obscure coupling mechanisms and make the mathematical
interpretation difficult.
Most current models of electrical activity in pancreatic b-cells
focus on explaining the complex bursting behaviour. The bursting
consists of an active phase when depolarization of the plasma
membrane causes Ca2+ to flow into the cell, alternating with a
silent phase when Ca2+ is extruded and the membrane potential
repolarizes. The cyclic alternation between depolarization and
repolarization of the plasma membrane leads to oscillations in
cytosolic Ca2+ concentrations [29,39–44].
The mechanism of the bursting of electrical activity and Ca2+
oscillations is based on the separation of timescales: a fast sub-
system, constituted by the membrane potential and delayed
rectifier potassium channels, generate the spiking during the active
phase, whereas a slow variable provide the negative feedback
responsible for the cyclical depolarization/repolarization [29,39–
44].
The main goal of this work is to provide new insights on the role
played by L-alanine in amino acid stimulated insulin secretion
(AASIS) and the potent enhancing effect on D-glucose-stimulated
insulin secretion (GSIS), as a first step to understanding the
complex metabolic relationships in the b-cell. We consider the
insulin secretion pathway divided in two main blocks: (i) core
metabolic network leading to ATP production (model 1)
(Figure 1. A) and (ii) electrical activity of ATP concentration-
driven channels that leads to Ca2+ influx resulting in insulin
granule exocytosis (model 2) (Figure 1. B), as detailed in the
Materials and Methods section.
Our model of GSIS and AASIS in the b-cell was validated
against wet-lab observations carried out on a functional clonal rat
insulin secreting b-cell line (BRIN-BD11) [45]. An ad hoc
experimental procedure was designed to obtain both single (D-
glucose or L-alanine) and combined (D-glucose + L-alanine) acute
stimulus dose-response curves (Figure 1. C).
We are interested in modelling the mechanisms of possible
metabolic stimulus-coupling effects rather than the time-depen-
dent behaviour of the system. Thus, all simulations were allowed
to run until the steady state was reached and all presented
experimental results were recorded after 20 minutes incubation
with stimuli of interest.
Results
Effect of D-glucose and L-alanine on cell integrity and
insulin secretory responses
BRIN-BD11cells integrity was investigated by neutral red assay
following 1 h incubation in Krebs Ringer Bicarbonate Buffer
(KRBB) supplemented with either various concentrations of D-
glucose (0{30mmol=l) in the presence or absence of 10 mmol/l
L-alanine or different concentrations of L-alanine (0{10mmol=l)
with/without supplementation with 16.7 mmol/l D-glucose.
These experiments were performed to ensure that cells viability
was not compromised under the incubation conditions tested
(Table 1).
Acute insulin secretion was concentration dependent with
respect to D-glucose only, rising over the range 1.1 mmol/l to
30 mmol/l from 0:48+0:09 ng/(mg protein 20 min) to
Glucose and Alanine Sensing in Pancreatic b-Cells
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Figure 1. GSIS and AASIS machinery in the pancreatic b-cell. A. Schematic diagram of metabolic processes accounted for in model
1. Reactions are represented as arrows (either uni- or bidirectional) and labelled v1to v24 (Table 2). Red arrows represent D-glucose specific
pathways, blue arrows indicate L-alanine-related reactions whereas black arrows denote viable metabolic routes common to both D-glucose and L-
alanine. B. Schematic representation of downstream electrophysiologic events and ion fluxes included in model 2. In clockwise order:
Na+/L-Alanine Co-transport (INazAla), delayed rectifying K+ current (IKzdr), K+ ATP-dependent current (IKzATP), K+ Ca2+-activated current (IKzCa2z ),
Ca2+ plasma membrane pump (ICa2zPump), Ca
2+ Uniporter (voltage-dependent) current (ICa2z ), Na+ voltage-gated current (INaz ), Na+/K+ pump
current (INazKz ), Na+/Ca2+ exchanger current (INazCa2z ). Current equations are given in Table 3. C. Experimental workflow. BRIN-BD11 cells were
washed with pre-warmed PBS and starved at 37̊C for 40 min in 1.1 mmol/l D-glucose KRBB. The cells were then washed again with PBS and
Glucose and Alanine Sensing in Pancreatic b-Cells
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0:83+0:08 ng/(mg protein 20 min) (Pv0:01), (Figure 2. A).
Administration of L-alanine only exhibited a robust dose-
dependent insulin secretion, increasing from 1:18+0:11 ng/(mg
protein 20 min) to 2:43+0:09 ng/(mg protein 20 min) (Pv0:001)
over the range 0.5 mmol/l to 10 mmol/l, (Figure 2. B). L-
alanine and D-glucose combined insulinotropic effects are non
trivial: addition of 10 mmol/l L-alanine to 1.1–30 mmol/l D-
glucose did not result in just an additive insulin secretion, but
rather in a synergistic increase (Pv0:001) in GSIS
(2:99+0:13 ng/(mg protein 20 min) and 3:47+0:09 ng/(mg
protein 20 min) at 1.1 and 30 mmol/l, respectively), (Figure 2.
C). Similarly addition of D-glucose both at basal (1.1 mmol/l) and
stimulatory (16.7 mmol/l) concentrations to 0.5–10 mmol/l L-
alanine led to a significant increase (Pv0:001) in insulin secretion
(Figure 2. D).
Effect of D-glucose and L-alanine on ATP and L-lactate
concentrations
An increase in ATP concentration is the main triggering event
in the K+ ATP-dependent pathway of nutrient-elicited insulin
secretion. Thus, our first goal was to build a simplified
mathematical model for ATP production (model 1), which could
reproduce experimental ATP data following D-glucose and/or L-
alanine stimulation.
In order to estimate the input fluxes for model 1 corresponding
to the range of D-glucose and L-alanine concentrations admin-
istered in the experiments (1:1{30mmol=l D-glucose and
0:5{10mmol=l L-alanine), stimuli consumption assays were
performed.
D-glucose consumption increased dose-dependently with re-
spect to D-glucose in the range (1:1{30mmol=l) from 0:17+0:29
mmol/(mg protein 20 min) to 3:10+0:49 mmol/(mg protein
20 min), (Figure 3. A). Analogously, L-alanine consumption
exhibited a dose-response increase from 0:18+0:13 mmol/(mg
protein 20 min) to 1:33+0:09 mmol/(mg protein20 min) in the
range 0:5{10mmol=l L-alanine (Figure 3. B). Addition of 10
mmol/l L-alanine to D-glucose enhanced D-glucose consumption
(Pv0:001) whereas L-alanine consumption was found unaffected
by the presence of D-glucose at both basal (1.1 mmol/l) and
stimulatory (16.7 mmol/l) concentrations (Figure 3. A–B).
Experimental ATP concentration changes obtained over a
20 min incubation period were found dose-dependent with respect
to D-glucose: increasing D-glucose in the range 1.1 mmol/l to 30
mmol/l increased ATP content from 2:02+0:19 nmol/(mg
protein 20 min) to 2:52+0:09 nmol/(mg protein 20 min).
Addition of 10 mmol/l alanine slightly increased ATP production
compared to D-glucose only, which became significant (Pv0:05)
at 16.7 mmol/l (2:28+0:12 nmol/(mg protein 20 min) vs
2:71+0:21 nmol/(mg protein 20 min)) and 30 mmol/l
(2:52+0:09 nmol/(mg protein 20 min) vs 2:81+0:15 nmol/(mg
protein 20 min)). 10 mmol/l. L-alanine administered on its own
led to an ATP production of 2:23+0:13 nmol/(mg protein 20
min), comparable to the value achieved with stimulatory
concentrations of D-glucose (Figure 3. C).
stimulated for 20 minutes in KRBB supplemented with different concentrations of D-glucose (G) only (1.1, 5, 16.7 and 30 mM), L-alanine (A) only (0.5,
1, 2, 5 and 10 mM) or their combination (G + A). After incubation, an aliquot of supernatant was removed for later quantification of D-glucose and L-
alanine consumption, L-lactate production and insulin secretion. Intracellular Ca2zconcentration was assessed by flow cytometry. Cells were then
washed with ice-cold PBS and lysed to assess viability, intracellular ATP concentration, intracellular L-glutamate concentration and protein content. (*)
Different lysis buffers were used depending on the biochemical parameter being measured.
doi:10.1371/journal.pone.0052611.g001
Table 1. BRIN-BD11 cells viability following 1 h incubation in stimuli-supplemented KRBB.
10 mmol/l L-alanine
D-glucose concentration [mmol/l] 2 +














BRIN-BD11 cells were incubated for 1 h in KRBB supplemented with either various concentrations of D-glucose (0–30 mmol/l) in the absence or presence of 10 mmol/l
L-alanine or L-alanine (0 10mmol=l) with/without supplementation with 16.7 mmol/l D-glucose. Results are expressed as percentage of control (11.1 mmol/l D-
glucose, same concentration of RPMI-1640 media used to maintain cells in culture). Data are mean 6 SD (n = 3). * Pv0:05 stimuli-free KRBB vs 16.7 mmol/l D-glucose
KRBB, + Pv0:05 stimuli-free KRBB vs 10 mmol/l L-alanine.
doi:10.1371/journal.pone.0052611.t001
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In order to fit the computational steady state ATP concentra-
tions to the experimental observations, a least-squared optimiza-
tion criterion was used to adjust a subset of the kinetic parameters
(V1max, K1ATP, V5max, K5GAP, k8f , k10f , k15f , kANT , b and K ). The
optimization procedure was set to minimize the objective function
(costmodel 1) given by the sum over the n ATP observations of the
squared normalized difference upon experimental ATP data








The optimization was implemented in MATLAB with the
routine fmincon with lower and upper bounds set to 1
100
X and 100X
of the initial values. As initial values, we used the parameters
reported in [33,46]. Note that the fitting has been carried out on
only 9 of the 10 ATP observations since the model is intended to
simulate ATP production following input with D-glucose or L-
alanine and not the basal ATP production/consumption of the
cell.
The results of the fitting are shown in Figure 3. C (solid red
and green lines for D-glucose only without/with applying 10
mmol/l equivalent L-alanine flux, respectively) and are in good
agreement with the experimental data (red diamonds and green
triangles for D-glucose in the absence/presence of 10 mmol/l L-
alanine, respectively).
In order to obtain a good fit, it was critical to adjust the
parameter k8f (reaction v8 in Figure 1. A), which represents the
forward kinetic constant for conversion of pyruvate into L-lactate
via lactate dehydrogenase. Pancreatic b-cells are characterized by
very low activity of lactate dehydrogenase, however clonal b-cell
lines exhibit higher L-lactate outputs with respect to primary cells
[47,48]. Indeed, we found that a high value of k8f was needed to
prevent a decrease in the steady state ATP concentrations towards
higher D-glucose input fluxes, especially if applied in conjunction
with L-alanine. Following a step increase in D-glucose input, the
overall flux along the glycolytic pathway leading to pyruvate
increases. If k8f is set to zero, the relative flux (relative to the sum
of all fluxes responsible for pyruvate breakdown) through reaction
15 (v15) increases and the relative flux through reaction 10 (v10)
decreases as a function of D-glucose influx.
A counterintuitive result of the simulations is that shifting to L-
lactate production by increasing k8f has the twofold advantage of
leading to NAD production which can serve as a further supply for
the glycolysis and redirecting some pyruvate that otherwise would
have been metabolised through reaction 15 (v15) consuming ATP
(see also Figure 4. A–C). Overall, this leads to progressive lower
steady state ATP concentrations across the whole D-glucose input
flux range. However, this results in a monotonic increasing
behaviour as the one observed experimentally (Figure 3. C).
For k8f ~325M
{1s{1, as found by fitting computational ATP
to experimental ATP, the model predicts a marked L-lactate
output when D-glucose influx is applied and an even more robust
levels when L-alanine input is also present (solid red and green
Figure 2. Effects of D-glucose and L-alanine on acute insulin secretion from BRIN-BD11 cells. BRIN-BD11 cells were cultured, allowed to
adhere overnight prior to being pre-incubated (40 min) in 1.1 mmol/l D-glucose and the acute (20 min) insulinotropic effects of D-glucose (GLC) only
(A), L-alanine (ALA) only (B) and combinations of both substrates (C, D) were tested. Values are mean 6 SD of at least 3 independent experiments. In
A, aPv0:01 vs basal (1.1 mmol/l) D-glucose KRBB; in B, bPv0:001 vs stimuli-free KRBB, cPv0:001 vs basal (0.5 mmol/l) L-alanine KRBB; in C, c as in B,
dPv0:001 vs absence of 10 mmol/l L-alanine; in (D), e Pv0:001vs absence of 1.1 mmol/l, fPv0:001 vs absence of 16.7 mmol/l D-glucose and g
Pv0:05 L-alanine KRBB supplemented with 1.1 mmol/l D-glucose compared to same concentrations supplemented with 16.7 mmol/l D-glucose.
doi:10.1371/journal.pone.0052611.g002
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lines, respectively in Figure 3. D). These results were confirmed by
experimental observations (red diamonds and green triangles,
respectively in Figure 3. D). L-lactate production increased dose-
dependently with respect to D-glucose from 0:057+0:009 mmol/
(mg protein 20 min) to 0:16+0:005 mmol/(mg protein 20 min) in
the range (1.1 to 30 mmol/l D-glucose) and was further enhanced
by supplementation with 10 mmol/l L-alanine (Pv0:001).
Marked L-lactate output in BRIN-BD11 cells following acute
stimulation with D-glucose has also been reported in other studies
[9,15,49].
Model 1 is characterized by 41 adjustable parameters and 10 of
them (V1max, K1ATP, V5max, K5GAP, k8f , k10f , k15f , kANT , b, K )
were used to fit the computational ATP data to the ATP
experimental observations. This subset of parameters was selected
based on sensitivity studies. Sensitivity is defined as the relative
change of the output variable (ATP in this case) due to a relative
change of one parameter. We were interested in identifying which
parameters could singularly shape the steady state ATP concen-









X and 2X, 4X, keeping the rest of the
parameters at their default values. We then visually inspected the
resulting curves looking for either increase/decrease in concen-
tration or variation in behaviour across increasing input flux.
Steady state ATP concentration is also sensitive to the values
assumed by some parameters related to the glycolytic pathway
(namely V1max, K1ATP, V2max, k3f , K4eq, V5max, K5GAP and
K5NAD).
Figure 4 shows the sensitivity analysis results for mitochondria-
related parameters as a function of D-glucose influx. It is well
established that the distribution of TCA fluxes determines the
status of the oxidative state. This is coupled with the respiratory
activity, which in turn affects both ATP synthase and ATP/ADP
translocation. Therefore, it is not surprising that simulations
indicated that steady state ATP concentration is sensitive to the
values of some specific parameters linked to either the distribution
of fluxes in the TCA cycle or the respiratory chain and ATP
synthase rates. For example, Figure 4. A–C show how the kinetic
constants that catalyse pyruvate breakdown, either by entering
TCA cycle through both reaction 10 and reaction 15 or disposal
through L-lactate (reaction 8), have a critical importance on steady
state ATP concentration. Increasing k8f results in both a slower
rise and a lower saturation level for ATP concentration as a
function of D-glucose influx (Figure 4. A). Conversely, increasing
the kinetic constant k10f leads to ATP increasing more steeply as a
function of D-glucose influx and culminating in higher steady state
level (Figure 4. B). The kinetic constant k15f also slightly
Figure 3. Effects of D-glucose and L-alanine on ATP and L-lactate production. All experiments were performed following 40 min pre-
incubation in 1.1 mmol/l D-glucose and 20 min acute stimulation. Values are mean 6 SD of at least 3 independent experiments. A. Experimental D-
glucose consumption as a function of D-glucose concentration. a 5 mmol/l D-glucose vs 5 mmol/l D-glucose plus 10 mmol/l L-alanine (Pv0:05), b D-
glucose vs same concentration of D-glucose supplemented with 10 mmol/l L-alanine (Pv0:01). B. Experimental L-alanine consumption as a function
of L-alanine concentration. C. Experimental total intracellular ATP concentration as a function of D-glucose influx in the absence or presence 10
mmol/l L-alanine (red diamonds and green triangles, respectively). c D-glucose vs addition of 10 mmol/l L-alanine (Pv0:01). Simulated steady state
ATP concentrations as a function of D-glucose influx (red and green solid lines) were fitted with a least square criterion to ATP observations by
adjusting the parameters V1max, K1ATP, V5max, K5GAP , k8f , k10f , k15f , kANT , b and K . D. Experimental L-lactate concentrations as a function of D-
glucose influx in the absence or presence of 10 mmol/l L-alanine (red diamonds and green triangle, respectively). d 16.7 mmol/l vs 30 mmol/l D-
glucose (Pv0:05), e 5 mmol/l D-glucose vs 5 mmol/l D-glucose plus 10 mmol/l L-alanine (Pv0:05) and f D-glucose vs addition of 10 mmol/l L-alanine
(Pv0:001). Predicted steady state L-lactate concentrations (red and green solid lines) were simulated using the standard set of parameters listed in
Table S1 that were obtained by fitting to ATP observations in panel C.
doi:10.1371/journal.pone.0052611.g003
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contributes to lowering the steady state ATP concentrations if
increased.
The kinetic constant for ATP translocation has a significant
impact on steady state ATP concentrations. kANT represents the
activity of ATP/ADP carrier and accounts for the energetic status
of the cell (state 3, 3.5 and 4, [46]). Higher kANT values result in a
marked reduction in steady state ATP concentrations due to a
decrease in both respiration and ATP synthase rates (Figure 4.
D).
The kinetic constant for proton leak across the mitochondrial
membrane (kleak ) can also affect steady state ATP concentration
especially when increased (4X, purple solid line), (Figure 4. E).
Other parameters that are critical in ATP concentration are
involved in the respiratory activity (Figure 4. F–H). The
respiratory rate is described by a differentiable function, which
has a saturation curve for NADH and behaves almost linearly
with respect to W until it reaches the threshold Wm, after which it
rapidly approaches zero. Varying the parameter Kaffects the
saturation curve for NADH : the quantity NAD½ z NADH½  is
conserved and equal to 1:07mM whereas K is equal to 2mM in the
original study [46] and was adjusted to 2:5mM in the ATP fitting.
Thus, for the limit case where all NAD is converted into NADH
(NAD?NADH,*1mM) selecting a K in the same range will




if NAD?0 and K~2:5mM) which will tend to zero
as K increases, resulting in lower vresp and consequently in a
reduction in ATP concentration.
Another viable way to boost the steady state ATP concentra-
tions is by increasing the parameters involved in the rate for ATP
synthase (kATP and b in vATP, reaction 24), (Figure 4. I–J).
Effect of D-glucose and L-alanine on L-glutamate
concentration
Model 1 simulations predicted an increase in the steady state
intracellular L-glutamate concentrations for increasing D-glucose
influx only and a marked shift upward of the curve when L-alanine
input was applied in combination (Figure 5. A–B). This is mainly
due to an increase in the fluxes through reactions 18
(aKGzNADH~GLUzNAD) and 19 (ALAzaKG
~PYRzGLU ), which both almost evenly contribute towards
production of L-glutamate. Due to the topology of the network the
flux v10 (PYRzNAD?AcCoA) has to be equal in magnitude
and sign (direction) to flux v11 (AcCoAzOAA?CIT) and
consequently v12 (CITzNAD?aKGzNADH). Moreover,
flux v15 (PYRzATP?OAAzADP) has to balance out flux v16
(discard of OAA). For these reasons, the balance at ‘‘node’’ OAA
leaves us with flux v13 that needs to be equal in magnitude and
opposite in sign to flux v14, which consumes GLU and OAA to
produce aKG and ASP. Flux v14 must be balanced by flux
through reactions 18 and 19, as previously stated.
Figure 4. Steady state ATP concentration sensitivity analysis for mathematical model 1. All simulations were performed using








X , 2X , 4X and
the resulting steady state ATP concentrations as a function of D-glucose influx are shown.
doi:10.1371/journal.pone.0052611.g004
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Mitochondrial metabolism is known to play a crucial role in
nutrient-stimulated insulin secretion not only for the production of
ATP, but also for the concomitant generation of stimulus-secretion
coupling factors, which are believed to be responsible for the full
and sustained insulin secretion. Indeed, L-glutamate is one of the
most controversial putative mitochondrial metabolism-derived
messengers.
In order to test whether L-alanine exploits its insulinotropic
effect through generation of the potential coupling agent L-
glutamate, an experiment was specifically designed. The acute
effects (20 min) in the presence of a stimulatory concentration of
D-glucose (16.7 mmol/l), L-alanine (10 mmol/l), their combina-
tion, 16.7 mmol/l D-glucose supplemented with a cell-permeable
L-glutamate precursor (5 mmol/l of dimethyl-glutamate,
DMGLU) and a negative control (16.7 mmol/l D-glucose plus
the mitochondrial poison FCCP, carbonyl cyanide p-trifluoro-
methoxyphenylhydrazone) on intracellular L-glutamate content
and corresponding insulin secretion levels were investigated.
DMGLU was successfully utilized in inducing a dose-dependent
increase in intracellular L-glutamate (results not shown) and the
concentration of 5 mmol/l of DMGLU administered in combi-
nation with 16.7 mmol/l D-glucose were found to produce an
‘‘artificial’’ increase in intracellular L-glutamate of 83:68+4:53
nmol/(mg protein 20 min) comparable in content to 79:89+5:51
nmol/(mg protein 20 min) induced by 16.7 mmol/l D-glucose
plus 10 mmol/l L-alanine. Insulin secretion stimulated by 16.7
mmol/l plus 5 mmol/l DMGLU was slightly, but significantly
(Pv0:05), decreased when compared to D-glucose only (Figure 5.
C) suggesting that the potent stimulus 16.7 mmol/l D-glucose plus
10 mmol/l L-alanine does not exploit its insulinotropic effect
primarily through generation of L-glutamate. Addition of 1 mmol/l
of the uncoupling poison FCCP successfully inhibited the
production of L-glutamate during D-glucose stimulation
(26:78% of intracellular L-glutamate, Pv0:05), although it did
not significantly affect insulin release, further corroborating the
hypothesis that L-glutamate content is not directly correlated with
insulin secretion.
Effect of D-glucose and L-alanine on Ca2z concentration
As shown in Figure 3. C, stimulatory concentrations of D-
glucose (16.7 mmol/l) and 10 mmol/l of L-alanine resulted in
comparable levels of ATP (2:28+0:12 vs 2:23+0:13 nmol/(mg
Figure 5. Relationship between intracellular L-glutamate levels and insulin output. A. Simulated steady state intracellular L-glutamate
concentrations produced in response to a step increase in D-glucose influx in the absence (solid red line) and presence of a fixed L-alanine input
equivalent to 10 mmol/l concentration administered in experiments (solid green line). B. Simulated intracellular L-glutamate concentrations as a
function of L-alanine input flux only (solid blue line) and with a fixed D-glucose input equivalent to 16.7 mmol/l concentration administered in the
experiments (solid dark green line). Both in A and B simulations results were obtained using mathematical model 1 with parameter values listed in
Table S1. C. BRIN-BD11 cells were cultured, allowed to adhere over a 24 h period prior to being pre-incubated (40 min) in 1.1 mmol/l D-glucose,
acutely stimulated for 20 min with either D-glucose only (16.7 mmol/l), L-alanine only (10 mmol/l), combinations of both substrates, 16.7 mmol/l D-
glucose supplemented with 5 mmol/l DMGLU and 16.7 mmol/l D-glucose plus 1 mmol/l FCCP. Supernatant was assayed for insulin secretion and
lysates were analysed for intracellular L-glutamate content. Values are mean 6 SD of at least 3 independent experiments. Statistical significance: L-
glutamate: a 16.7 mmol/l D-glucose vs 16.7 mmol/l D-glucose plus FCCP (Pv0:05), b 16.7 mmol/l D-glucose vs 16.7 mmol/l D-glucose supplemented
with 10 mmol/l L-alanine (Pv0:002), c 16.7 mmol/l D-glucose vs 16.7 mmol/l D-glucose plus 5 mmol/l DMGLU (Pv0:001), d 10 mmol/l L-alanine vs
16.7 mmol/l D-glucose plus 10 mmol/l L-alanine (Pv0:05).Insulin: e 16.7 mmol/l D-glucose vs presence of 10 mmol/l L-alanine (Pv0:001), f 16.7
mmol/l D-glucose vs addition of DMGLU (Pv0:05), g 10 mmol/l L-alanine vs supplementation with 16.7 mmol/l D-glucose (Pv0:05), h 16.7 mmol/l D-
glucose plus 10 mmol/l L-alanine vs 16.7 mmol/l D-glucose supplemented with 5 mmol/l DMGLU (Pv0:001).
doi:10.1371/journal.pone.0052611.g005
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protein 20 min)), despite their insulin secretion levels differed
markedly (Figure 2. A–B). These data suggest that some other
mechanism beside ATP must be involved in insulin secretion.
L-alanine is taken up by b-cells at very high rate in BRIN-BD11
cells (one order of magnitude higher that of L-glutamine, [16]) and
it is co-transported with Na+ with a stoichiometric ratio 1:1. This
could lead to a substantial shift in the intracellular Na+
concentration, which could affect Ca2+ handling and ultimately
account for the disparity in insulin secretion.
Intracellular Ca2+ concentration responses to acute stimulation
with D-glucose (16.7 mmol/l), L-alanine (10 mmol/l) and their
combination are presented in Figure 6. Intracellular Ca2+
concentration responses were found to positively correlate with
insulin secretion.
The potent insulinotropic stimulus 16.7 mmol/l D-glucose plus
10 mmol/l L-alanine was associated with a relative fold increase of
218:44+6:32% and 951:22+19:51% in intracellular Ca2+
concentration and insulin secretion respectively against
112:70+9:23% and 256:09+21:95% exhibited by D-glucose
only and 210:96+7:34% and 665:58+34:15% by L-alanine only.
To determine the relative importance of oxidative metabolism
and Na+ co-transport in L-alanine-induced stimulation of insulin
secretion, an experiment was designed whereby either 10 mmol/l
of a non-metabolizable L-alanine analogue, AIB (a-aminoisobu-
tyric acid), which shares the same co-transport mechanism of the
amino acid, or the mitochondrial poison oligomycin (1.8 mg/ml)
were employed.
When 10 mmol/l L-alanine were replaced by equimolar
amounts of AIB, either when administered alone or supplemented
with 16.7 mmol/l D-glucose, both intracellular Ca2+ concentra-
tion (from 210:96+7:34% to 175:46+10:22%, Pv0:01 and
218:44+6:32% to 161:99+13:12%, Pv0:01, respectively) and
insulin release (from 665:58+34:15% to 226:83+29:27%,
Pv0:001 and 951:22+19:51% to 517:07+29:27%, Pv0:001,
respectively) were markedly decreased. The addition of oligomycin
to 10 mmol/l L-alanine with/without D-glucose provoked
substantial decrease in both Ca2+ levels (Pv0:01) and insulin
release (Pv0:001). Experimental results substantiated our hypoth-
esis that Na+ co-transport may have a significant impact on L-
alanine induced insulin secretion. However, Na+ co-transport is
not the only factor responsible for increased insulin secretion as
suggested by the results obtained with 10 mmol/l L-alanine vs 16.7
mmol/l plus 10 mmol/l L-alanine. Ca2+ level was slightly (from
210:96+7:34% vs 218:44+6:32%), but not significantly, en-
hanced, while the corresponding insulin secretion was markedly
increased (from 665:58+34:15% to 951:22+19:51%).
In order to characterise further the role of amino acid/Na+ co-
transport on Ca2+ dynamics, we built a simplified mathematical
model of Ca2+ handling, based on the framework of Fridlyand, as
described in the Materials and Methods section. The model main
Figure 6. Effects of D-glucose and/or L-alanine on intracellular Ca2+ and insulin secretion. BRIN-BD11 cells were cultured, allowed to
adhere over a 24 h period prior to being pre-incubated (40 min) in 1.1 mmol/l D-glucose, acutely stimulated for 20 min with either D-glucose only
(16.7 mmol/l), L-alanine only (10 mmol/l, with/without 1.8 mg/ml oligomycin), combinations of both substrates with/without oligomycin, 16.7 mmol/l
D-glucose supplemented with 10 mmol/l AIB and 10 mmol/l AIB only. Samples were assayed for insulin secretion and intracellular Ca2+ concentration
as described in the Materials and methods section. Values are mean 6 SD of at least 3 independent experiments. Statistical significance:
Intracellular Ca2+ concentration: a D-glucose only vs addition of 10 mmol/l L-alanine (Pv0:001), b D-glucose only vs addition of 10 mmol/l AIB
(Pv0:01), c D-glucose plus L-alanine vs addition of oligomycin (Pv0:001), d D-glucose plus L-alanine vs D-glucose plus AIB (Pv0:01), e L-alanine vs
AIB (Pv0:01), f L-alanine vs addition of oligomycin (Pv0:01). Insulin secretion: g D-glucose vs addition of 10 mmol/l L-alanine (Pv0:001), h D-
glucose plus L-alanine vs L-alanine only (Pv0:01), i D-glucose vs addition of 10 mmol/l AIB (Pv0:001), l D-glucose plus L-alanine vs addition of
oligomycin (Pv0:001), m D-glucose plus L-alanine vs D-glucose plus AIB (Pv0:001), n L-alanine vs AIB (Pv0:001), o L-alanine vs addition of
oligomycin (Pv0:001), p D-glucose vs addition of AIB (Pv0:001).
doi:10.1371/journal.pone.0052611.g006
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input is metabolism-derived ATP production (kADP, (72)) and it
does not distinguish whether the ATP is obtained from D-glucose
or L-alanine oxidation.
We then introduced an additional Na+ current (INazAla,) to
model the Na+/L-alanine co-transport across the plasma mem-
brane as detailed in the Materials and methods.
Pancreatic b-cells are characterized by an oscillatory electrical
and Ca2z activity upon stimulation resulting in an oscillatory
insulin secretion. The electrical activity shows complex patterns
and a large body of theoretical and experimental studies have
focussed on trying to clarify the mechanism involved
[14,25,27,41,42,50–52].
The time course behaviour for the state variables V , ATP,
Ca2z and Naz with or without applying INazAla is shown in
Figure 7 (solid blue line and solid black line, respectively). In
response to ATP (simulated with standard parameter values listed
in Table S2 and kADP~0:05ms
1), the membrane potential
exhibited peaks at *0mV and troughs at *{69mV vs *{4mV
and *{64mV when INazAla (kNazAla~50) was applied. Ca2z,
Naz and ATP show the typical oscillating pattern, however the
frequency was also altered when INazAla was applied from
*1:6Hz (kNazAla~0) to *5Hz (kNazAla~50).
Metabolism-derived ATP raise was simulated by increasing the
rate constant for ATP production over a broad range of values
(from kADP~0:0001ms
1 to 0:5ms1, corresponding to basal
ATP production and virtually no stimuli to a saturating region),
while the impact of Naz co-transport for increasing concentration
of L-alanine was modelled by the adjustable parameter kNazAla in
the range 0{400. Simulations were run until an oscillatory
stationary state was reached and the mean of the state variables
and the channels’ currents was computed over time.
The effect of a step increase in ATP production and Naz co-
transport on steady state intracellular concentrations of Ca2z,
ATP and Naz and the main channels currents included in the
model, Ca2+ uniporter (voltage-dependent) current (ICa2z ), Ca2+
plasma membrane pump (ICa2zPump), K+ Ca2+-activated current
(IKzCa2z ), Na+/Ca2+ exchanger current (INazCa2z ), Na+/K+
pump current (INazKz ), and K+ ATP-dependent current (IKzATP),
is presented in Figure 8. A step increase in kADP resulted in an
increase in the intracellular ATP concentration, which caused a
decrease in the current flowing through the K+ATP-dependent
channel. The consequent plasma membrane depolarization led to
Ca2+ influx through the Ca2+ voltage dependent channel as
expected.
Applying INazAla resulted in a substantial increase in the mean
Ca2z concentration, supporting the hypothesis that the raise in
intracellular Naz concentration due to the symport may play a
significant role in insulin secretion. The intracellular ATP
concentration was slightly reduced as the system increases the
activity of the Ca2z pump and the Na+/K+ pump to extrude the
excess of Naz (Figure 8. E and Figure 8. H, respectively), both
ATP-fuelled. Moreover, the raise in Ca2z concentration directly
accelerates ATP consumption (72). This decrease in ATP
concentration led to a slight increase in the outward current
through K+ ATP-dependent channel, especially for low kADP
values. However, applying INazAla led to a marked increase in the
Figure 7. Electrical activity and intracellular concentrations of ATP and cations. Time-dependent changes in the membrane potential V
(A), intracellular ATP concentration (B), intracellular Ca2z concentration (C) and intracellular Naz concentration (D) are depicted. The simulation
with the default parameters given in Table S2 and kADP~0:05ms
{1 is represented by the solid black curve. The effect of applying INazAla to model
Na+/L-alanine co-transport was simulated by increasing kNazAla from 0 to 50 in equation 69 (solid blue line).
doi:10.1371/journal.pone.0052611.g007
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K+-Ca2+ activated current (Figure 8. F) and in the current
flowing through the K+ delayed rectifier channel (not shown).
Along with the Ca2+ pump current, the Na+/Ca2+ exchanger
current (Figure 8. G) increased also, trying to counteract further
influx of Ca2z. However, the increase in the Ca2z voltage
dependent channel current (Figure 8. D) was substantially more
marked, resulting in a net raise in the intracellular Ca2z
concentration.
Both Ca2+/insulin secretion experiments and preliminary
computational results supported the hypothesis that L-alanine
insulinotropic properties could be, at least in part, ascribed to it
being co-transported with Naz. The model inputs are constituted
by kADP and kNazAlawhereas the output is given by the Ca
2z
concentration. In order to validate our model with D-glucose or L-
alanine insulin secretion dose-response curves, we made the
following simplifying assumptions:
(i) Insulin secretion increases linearly with the bulk intracel-






(ii) kADPincreases linearly with either D-glucose concentration
or L-alanine concentration when they are administered
separately. Figure 3. A–B demonstrates a quasi-linear
relationship between D-glucose or L-alanine concentra-
tions and their correspondent uptake. kADP is the kinetic
constant for metabolism-driven ATP production and it is
thus proportional to the nutrients uptake, (3);
kADP~
kADP GLC GLC½ , if ALA½ ~0
kADP ALA ALA½ , if GLC½ ~0

ð3Þ
(iii) kADPfor 10 mmol /l L-alanine is equal to kADP for 16.7
mmol/l D-glucose. This follows from the experimental
ATP concentration corresponding to the highest L-alanine
concentration administered (10 mmol/l) being comparable





(iv) The constant kNazAla increases linearly with the concen-
tration of L-alanine present in the buffer, (5).
Figure 8. Mean Ca2z, ATP, Naz concentrations and main channels’ currents modulated by kADP and kNazAla. Ca
2z handling model
simulations were run until an oscillatory steady state was reached and subsequently the mean was computed over time for each state variable and
current in the system. Standard parameter values listed in Table S2 were used. The effect of a step increase in kADP (in the range 0:0001{0:05ms
{1)
for various values of the parameter kNazAla on intracellular Ca
2z, ATP, Naz concentrations is reported in panels A–C. The effect of a step increase
in kADP (in the range 0:0001{0:05ms
{1) for the parameter kNazAla assuming the values 0,10,20,200,400 on the main currents included in the model,
ICa2z , ICa2zPump, IKzCa2z , INazCa2z , INazKz , IKzATP is shown in panels D–I.
doi:10.1371/journal.pone.0052611.g008
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kNazAla~kNazAla{Ala ALA½  ð5Þ
We used a least-squared optimization criterion to fit the
computational steady state intracellular Ca2z concentrations to
the experimental insulin secretion observations. The fitting was
performed using 11 observations in total taken from Figure 2. A–
B: 1 with neither D-glucose nor L-alanine, 5 with increasing
concentrations of D-glucose only and 5 with increasing concen-
trations of L-alanine only. We employed the MATLAB routine
fminsearch to find k
Ca2z{Insulin
, kADP GLC and kNazAla{Alawhich
minimise the objective function costmodel 2 given by the squared
difference between experimental insulin secretion data and






  2 ð6Þ
Where n represents the number of experimental points,
Insulinexpi represents one of the insulin observations, the constant
kCa2z{Insulin scales the simulated Ca
2z output to the i experi-
mental insulin secretion values and Ca2z kADPi ,kNazAlaið Þ is the
simulated mean steady state Ca2z value with kADP and kNazAla as
per assumptions (ii)-(iv).
Figure 9. A shows the simulated steady state Ca2z concen-
tration as a function of kADP (top x axis and right y axis, in red)
overlaid to the experimental D-glucose insulin secretion dose
response curve (bottom x axis and left y axis, in black). The top x
axis was scaled to the bottom x axis with kADP{GLC and the right y
axis was scaled to the left y axis with kCa2z{Insulin, both found with
the fitting.
Figure 9. Comparison of simulated mean Ca2z levels and experimental insulin secretion dose-response curves. A. Simulated steady
state Ca2z concentrations as a function of kADP (top x axis and right y axis, in red) are overlaid onto the experimental D-glucose insulin secretion
dose-response curve (bottom x axis and left y axis, in black). The top x axis was scaled to the bottom x axis with kADP{GLC and the right y axis was
scaled to the left y axis with kCa2z{Insulin, both found with the fitting. B. Simulated steady state Ca
2z concentrations as a function of kNazAla (top x
axis and right y axis, in blue) are overlaid to the experimental L-alanine insulin secretion dose response curve (bottom x axis and left y axis, in black).
The top x axis was scaled to the bottom x axis with kNazAla{Ala and the right y axis was scaled to the left y axis with kCa2z{Insulin, both found with the
fitting. The line annotated kADP!kNazAla shows the simulated steady state Ca2z concentration if kADP and L-alanine concentration follow
assumption (ii). The patch delimited by the lines annotated kADP~0:011ms
1 and kADP~0:0022ms
1 , correspondent to simulated steady state value




of it, shows that even a large variation in kADP has only a modest effect on Ca
2z.
Administration of 10 mmol/ AIB with or without supplementation with 16.7 mmol/l D-glucose can be simulated by setting kNazAla~400 (same value
as 10 mmol/l L-alanine) in both cases and kADP~0:011ms
1 corresponding to 16.7 mmol/l D-glucose-derived ATP production (blue square) or
kADP~0:00025ms
1 corresponding to virtually no metabolism-derived ATP production (cyan square), respectively. All simulations were performed
using standard parameter values enumerated in Table S2 except for kADP and kNazAla that assumed the values herein specified.
doi:10.1371/journal.pone.0052611.g009
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Analogously, Figure 9. B shows the simulated steady state
Ca2z concentration as a function of kNazAla (top x axis and right y
axis, in blue) overlaid to the experimental L-alanine insulin
secretion dose response curve (bottom x axis and left y axis, in
black). The top x axis was scaled to the bottom x axis with
kNazAla{Ala and the right y axis was scaled to the left y axis with
kCa2z{Insulin, both found with the fitting.
The line annotated kADP!kNazAla shows the simulated steady
state Ca2z concentration if kADP and L-alanine concentration are
as laid out in assumption (ii).
The patch delimited by the lines annotated kADP~0:011ms
1
and kADP~0:0022ms
1, correspondent to simulated steady state





of it, shows that even a large variation in kADP has only a
modest effect on Ca2z.
The parameterised model was utilised to predict Ca2z levels in
other experimental conditions tested, such as administration of
AIB. AIB is a non-metabolizable L-alanine analogue and thus does
not lead to ATP production. However, AIB shares the same Na+
co-transport mechanism of L-alanine. Therefore, the administra-
tion of 10 mmol/ AIB with or without supplementation with 16.7
mmol/l D-glucose can be simulated by setting kNazAla~400 (same
value as 10 mmol/l L-alanine) in both cases and
kADP~0:011ms
1corresponding to 16.7 mmol/l D-glucose-de-
rived ATP production (blue square) or kADP~0:00025ms
1
corresponding to virtually no metabolism-derived ATP production
(cyan square), respectively (Figure 9. B). Note that experimental
insulin secretion value following 10 mmol/l L-alanine only
challenge is comparable to the value achieved when equimolar
amount of AIB were supplemented with 16.7 mmol/l D-glucose.
The model is able to predict Ca2+ levels when D-glucose only,
L-alanine only and D-glucose plus AIB, are administered.
However, experimental data in Figure 6 indicate that Ca2+
content is not the only player in insulin secretion when D-glucose
and L-alanine are administered together. This finding suggests
that the amplifying pathway, through ATP levels and possibly the
putative messengers identified by the simulation of model 1, may
markedly modulate GSIS in the presence of L-alanine. Therefore,
currently the model is not able to predict correctly insulin secretion
output when both stimuli are present together. A quantitative
description for ATP-Ca2+ interaction as well as further character-
ization of the mechanism underlying the amplifying pathway are
needed to overcome this limitation.
Discussion
In this study, we built a comprehensive model of the role played
by D-glucose and the amino acid L-alanine in promoting insulin
secretion both independently and in combination to modulate
GSIS in vitro. Previous experimental studies [5,6,8,10,53] have
focussed on how L-alanine could enhance GSIS rather than
considering the insulinotropic properties of the amino acid itself.
Most GSIS mathematical models available in the literature focus
on either metabolism or Ca2+ handling and none of these include
possible mechanisms of action for amino acids. L-alanine is co-
transported with Na+ ions into pancreatic b-cells where it is then
converted to pyruvate and therefore can lead to insulin secretion
by both directly depolarizing the plasma membrane and by
oxidative metabolism.
We studied this using two separate models: a core metabolic
model leading to ATP production (model 1) (Figure 1. A) and a
Ca2+ handling model described by voltage-gated currents (model
2) (Figure 1. B).
We validated the models against in vitro observations on the
BRIN-BD11 cell line using the workflow illustrated in Figure 1.
C.
Total intracellular ATP observations exhibited a dose depen-
dent response with respect to D-glucose which was further boosted
by addition of 10 mmol/l L-alanine. Key kinetic parameters
(V1max, K1ATP, V5max, K5GAP, k8f , k10f , k15f , kANT , b and K ) were
fitted using a least squared criterion to make the model match
ATP experimental results.
Simulations performed on the parameterized model 1 demon-
strated a substantial increase in tzhe steady state concentration of
L-glutamate when L-alanine influx was applied and even more
strikingly if it was applied in conjunction with D-glucose influx
(Figure 5. A–B). L-glutamate has been object of intense
investigations and has been proposed to be a stimulation-secretion
coupling factor in the amplifying pathway of insulin secretion
[13,54–56], although this hypothesis is controversial [57]. In order
to test whether L-alanine could exploit its insulinotropic effects for
both AASIS and GSIS through L-glutamate, we induced
‘‘artificially’’ an increase in the intracellular concentration of L-
glutamate and we performed insulin secretion assays in parallel. A
raise in intracellular L-glutamate concentration comparable in
content to the increase induced by 10 mmol/l L-alanine at
stimulatory concentration of D-glucose (16.7 mmol/l) was attained
by using an L-glutamate precursor (5 mmol/l of di-methyl-
glutamate). However, the corresponding insulin secretion was
slightly but significantly decreased with respect to control (16.7
mmol/l D-glucose only with no other addition) without affecting
cell viability (latter result not shown), (Figure 5. C). These results
do not support the hypothesis that L-alanine impacts on insulin
secretion solely via an increase in L-glutamate. However, the rise
in L-glutamate may not be casually connected to L-alanine
challenge. Our experiment focussed on clarifying the effect that L-
glutamate generation may have per se in promoting insulin
secretion. However, it remains plausible that L-glutamate plays
an important coupling role in pancreatic b-cells, but other
components may be necessary. It would be interesting to
investigate whether the L-alanine-induced raise in Ca2+ levels
had an effect on L-glutamate-mediated insulin secretion since it
has been reported that L-glutamate failed to induce insulin
secretion at basal intracellular Ca2+ concentration [13]. Further-
more, L-alanine-induced L-glutamate generation may be coupled
to production of other products that we failed to reproduce in our
experiments, which may be essential for the full development of L-
glutamate-regulated insulin secretion. Interestingly, a recently
published study [58] has shown, using high resolution immuno-
cytochemistry techniques, that it is neither the increase in cytosolic
nor intra-vesicular L-glutamate concentration that is responsible
for the amplification of insulin secretion, but rather the flux of L-
glutamate through the secretory granules that modulates both the
pH and membrane potential which in turn shape the insulin
response. However, the vast amount of conflicting data in
literature, the very variable experimental conditions, numerous
models employed, and the complexity of the pathways involved
prevent a clear-cut interpretation. Therefore, future work should
attempt to dissect the role of intracellular L-glutamate and
potential cofactors in insulin secretion.
To gain further insights into what extent insulin secretory
responses can be modulated by electrogenic Na+ co-transport, L-
alanine was replaced in KRBB (with or without D-glucose
supplementation) with equimolar amounts of a-aminoisobutyric
acid (AIB). AIB is an L-alanine non metabolizable analogue, thus
it shares the same co-transport mechanism of the amino acids
without the capability of being oxidised and hence producing
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ATP. The latter finding is consistent with a previous study [17]
where ouabain, a Na+ pump blocker, was used to demonstrate that
L-alanine promotion of Na+ influx strongly affects insulin
secretion. Moreover, it was demonstrated that replacing extracel-
lular Na+ ions with equimolar concentration of N-methyl-D-
glutamine (NMDG) in KRBB was effective in abolishing the
effects of AIB and L-alanine electrical activity on elevation of
intracellular Ca2+ [59] and insulin secretion, while GSIS was
unaffected [17]. Interestingly, adding the mitochondrial poison
oligomycin to L-alanine (alone or supplemented with D-glucose)
and consequently almost abolishing the ATP output or replacing it
Table 2. Mathematical model of core metabolic processes in pancreatic b-cells: reactions list.
Reaction Rate expression Eq.
1. GLC+ATPRF6P+ADP v1~
V1 max½ATP½GLC




K2F6Pz½F6Pð Þ K2ATPz½ATPð Þ (28)
3. FBPRout v3~k3f ½FBP (29)









K5GAPz½GAPð Þ K5NADz½NADð Þ
(31)
6.DPG+ADPRPEP+ATP v6~k6f ½DPG½(Atot{ATP)ð Þ (32)
7. PEP+ADPRPYR+ATP v7~
V7 max½PEP½(Atot{ATP)
K7PEPz½PEPð Þ K7ADPz½(Atot{ATP)ð Þ
(33)
8. PYR+NADHRLAC+NAD+ v8~k8f ½PYR½(Ntot{NAD) (34)
9. LACRout v9~k9f ½LAC (35)
10. PYR+NAD+RAcCoA+NADH v10~k10f ½PYR½NAD (36)
11. AcCoA+OAARCTT v11~k11f ½OAA½AcCoA (37)
12. CTT+NAD+Ra2KG+NADH v12~k12f ½CIT ½NAD (38)
13. a2KG+2.NAD++ADPROAA+2.NADH+ATP v13~k13f ½a{KG½NAD½(Atot{ATP) (39)





15. PYR+ATPROAA+ADP v15~k15f ½PYR½ATP (41)
16. OAARout v16~k16f ½OAA (42)
































1z exp a DW{DWmð Þð Þ
 
(49)
24. ADP+Pi+3.H+e = ATP+H2O+3.H+
vATP ATP,DWð Þ~kATP
2
1z exp b ATP{ATPcrit DWmð Þð Þð Þ
{1
 
















Abbreviations of substrates: GLC, D-glucose; ATP, adenosine triphosphate; F6P, fructose-6-phosphate; ADP, adenosine diphosphate; FBP, fructose-1,6-
biphopshate; GAP, glyceraldehyde 3-phosphate; NAD and NADH, nicotinamide adenine dinucleotides; DPG, 1,3-biphosphoglycerate; PEP, phosphoenol pyruvate;
PYR, pyruvate; LAC, L-lactate; AcCoA, acetyl coenzyme A; OAA, oxaloacetate; CIT, citrate; a{KG, a-ketoglutarate; GLU, L-glutamate; ASP, L-aspartate; ALA, L-
alanine; Hz , hydrogen ion; Pi, inorganic phosphate.
doi:10.1371/journal.pone.0052611.t002
Glucose and Alanine Sensing in Pancreatic b-Cells
PLOS ONE | www.plosone.org 14 March 2013 | Volume 8 | Issue 3 | e52611
with AIB led to a substantial and comparable decrease in insulin
release.
The analysis of our model simulations indicates that both high
intracellular ATP and Ca2+ concentrations are necessary to
develop full insulin secretory responses, in agreement with
previously published findings [1,3,11,14,17,40,52,56,60]. Impor-
tantly the model confirmed that Na+ co-transport acts synergis-
tically with membrane depolarization and thus K+ATP channel
independent mechanisms of stimulation of Ca2+ levels in the b-cell
that are essential for promotion of insulin secretion. Furthermore,
both models combined suggest that the potent insulinotropic
stimulus D-glucose plus L-alanine generates production of an, as
yet, unidentified messenger involved in the amplifying pathway of
insulin secretion.
Collectively experimental data and simulation results suggest
that L-alanine is particularly effective in inducing insulin secretion
through three independent and complimentary mechanisms of
action. Firstly, L-alanine is metabolized at high rates [6] and, thus,
can lead to a conspicuous ATP production resulting in insulin
secretion through K+ATP dependent triggering pathway. Simula-
tions carried out on model 1 suggest that L-alanine is also the
source of metabolically derived putative stimulus-secretion mes-
sengers in insulin secretion, such as L-glutamate and citrate (latter
result not shown), which could account for the full development of
insulin secretion through the amplifying pathway. Moreover, L-
alanine / Na+ co-transport mediated depolarization accounts for a
substantial proportion of L-alanine stimulated insulin secretion.
However, experimental data indicate that Ca2+ content is not
the only player in insulin secretion when D-glucose and L-alanine
are administered together (Figure 6).
In summary, L-alanine could be exploited for future studies of
the mechanism(s) of powerful insulinotropic agents, as its action is
robust, reliable, and controllable, contrarily from most commer-
cially available drugs that lack coupling between metabolism and
electrical activity.
The current model has multiple limitations. However, it is the
only currently available model that accounts for amino acids-
dependent insulin secretion mechanisms. Limitations of the
current model includes the fact that model 1 in kinetic rates are
either modelled using mass action or Michaelis-Menten functional
expressions and do not take into account neither cooperativity nor
other regulatory activities, like the Ca2+ effects on the mitochon-
drial dehydrogenases. However, the model is able to capture the
essential behaviour of the experimental data, suggesting that the
principal pathways involved are modelled with sufficient detail.
Furthermore, details of Na+ co-transport mechanism are still
unknown and more comprehensive experimental data are needed
to develop more informed expressions for the mathematical model
2 to be tested.
Our description of the b-cell’s core metabolic processes and
Ca2+ handling could enable testing of metabolic hypotheses and
drug actions and constitute a valuable tool in planning targeted
experiments. Furthermore, this study could constitute a starting
point for a future refinement of individual steps generating
mitochondrial derived coupling factors and Ca2+ handling, thus




Reagents. RPMI-1640 culture media, foetal bovine serum
(FBS) and plastic were purchased from Gibco (Glasgow, UK). All
other chemicals were obtained from Sigma-Aldrich Chemical
(Poole, Dorset, UK) unless stated otherwise.
Culture of BRIN-BD11 cells. BRIN-BD11 cells were grown
and maintained in RPMI-1640 tissue culture medium with 10%
(v/v) foetal bovine serum, 0.1% antibiotics (100 units/ml penicillin
and 100 mg/ml streptomycin), 2 mmol/l L-glutamine and 11.1
mmol/l D-glucose, pH 7.4. BRIN-BD11 cells were grown and
maintained at 37uC in a humidified atmosphere of 5% CO2 and
95% air using a Forma Scientific incubator (Marietta, OH, USA).
Cells were cultured in 50–70 ml of RPMI-1640 tissue culture
medium in T175cm2 sterile tissue culture flasks (Greiner) and
passaged every 2–3 days by mechanical detachment with 0.025%
(w/v) trypsin/EDTA solution. The passage number of cells used in
this study was in the range 18–30.
The general experimental workflow is illustrated in Figure 1.C.
Briefly, BRIN-BD11 cells were seeded into either 24-well plates
or T75cm2/T175cm2 flasks depending on the parameter to be
assayed and were allowed to adhere over night before experi-
ments. The following day, cells were washed with calcium and
magnesium free phosphate buffer saline (PBS) and pre-incubated
at 37uC for 40 min in Krebs Ringer bicarbonate buffer (KRBB)
(115 mmol/l NaCl, 4.7 mmol/l KCl, 1.28 mmol/l CaCl2, 1.2
mmol/l KH2PO4, 1.2 mmol/l MgSO4̇7H20, 10 mmol/l
NaHCO3, 1 g/l BSA, pH 7.4) supplemented with 1.1 mmol/l
D-glucose. Supernatant was carefully removed and discarded
before cells were washed with PBS.
This was followed by an incubation period of 20 min in KRBB
as described above but supplemented with either D-glucose only
(1.1, 5, 16.7, 30 mmol/l) or L-alanine only (0.5, 1, 2, 5, 10 mmol/l)
or various combinations of D-glucose and L-alanine.
After incubation, supernatant was removed, centrifuged (400 g
for 5 min at 4uC) and stored at 220uC for later determination of
insulin and metabolites (D-glucose, L-alanine and L-lactate).
Intracellular Ca2+ concentration was assessed by a cell-based
experiment performed with flow cytometric techniques. Cells were
also analysed for their respective ATP and L-glutamate content
(lysates were stored at 280uC).
All the results (except cell viability measurements and intracel-
lular Ca2+ concentrations) were normalized with respect to the cell
protein content.
Each experiment was carried out on at least three independent
cultures of BRIN-BD11 cells.
Cell viability measurements. Cell viability was assessed by
neutral red uptake assay which provides a quantitative estimation
of the number of viable cells based on their ability to incorporate
and bind the dye neutral red in lysosomes.
BRIN-BD11 cells were seeded in 24 well plates (1:5|105 per
ml) and let to adhere overnight.
BRIN-BD11 cells were incubated for 1 h in KRBB supple-
mented with different concentrations of either D-glucose or L-
alanine or various combinations of both in the presence of
DMSO-dissolved neutral red (100 mg/ml). Subsequently, cells
were washed twice with PBS and the dye was extracted by
disruption with acid ethanol (alcohol/glacial acetic acid, 50:1 v/v).
An aliquot (100 ml) of the resulting solutions was transferred to a
96-well plate and absorbance at 540 nm was recorded using a
microplate spectrophotometer (Molecular Devices SpectraMax
Plus 384, Sunnyvale, CA, USA).
Insulin Secretion. BRIN-BD11 cells (1:5|105 per ml) were
seeded in 24-well plates and allowed to adhere overnight. Cells
were then starved and stimulated as described above and aliquots
of incubation KRBB were stored at 220uC and subsequently
assayed for insulin using a Mercordia (Uppsala, Sweden)
ultrasensitive rat insulin enzyme-linked immune-absorbent assay
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(ELISA) according to the manufacturer’s instructions. Absorbance
readings were performed using a microplate spectrophotometer
(Molecular Devices SpectraMax Plus 384, Sunnyvale, CA, USA).
It was ensured that cell density and insulin content were
not significantly different under any of the incubation conditions
[6].
BRIN-BD11 cells were lysed by addition of 150 ml of 1X RIPA
buffer to each well and incubation for 1 h. Lysates were then
transferred to Eppendorfs tubes, centrifuged at 14000 g for
15 min at 4uC. Supernatant were then frozen at 220uC for later
protein analysis.
Total intracellular ATP concentration. BRIN-BD11 cells
were seeded in a T175cm2 sterile tissue culture flask (2:0|107cells
per flask) and allowed to adhere overnight. After starvation and
stimulation as described above, cells were trypsinized and re-
suspended in KRBB. The cell suspension was spun at 400 g for
Table 3. Mathematical model of Ca2z handling in pancreatic b-cells: Nernst potential and channels currents list.
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5 min at 4uC, supernatant was removed and pellets were shock
frozen in liquid N2 before being stored at 280uC. Cells were lysed
with a suitable lysis buffer and the ATP released was quantified
using a commercial available kit (ATP Bioluminescence Assay Kit
HS II, Roche, Mannheim, Germany) according to instructions of
the manufacturer and results were recorded using a luminometer
(Turner Biosystems, ModulusTM Microplate Multimode Reader,
Sunnyvale, CA). The assay is based on the ATP dependency of the
light emitting luciferase-catalysed oxidation of luciferin for
accurate measurement of extremely low concentration of ATP.
An aliquot of cells lysates was stored at 280uC for later
determination of proteins content.
Intracellular Ca2+ concentration. BRIN-BD11 cells were
seeded in a T75cm2 flask (1:5|106 cells per flask) and allowed to
adhere overnight. Cells were washed with PBS, incubated with
complete media loaded with 1 mM of the probe Fluo-4 AM
(Molecular Probes, Invitrogen Life Technologies, CA, USA) for 1
h, washed twice with PBS, trypsinized, re-suspended in KRBB
supplemented with 1.1 mmol/L D-glucose and starved for 40 min.
Subsequently, cells were briefly centrifuged (400 g for 5 min at
4uC), washed with PBS, briefly centrifuged again and incubated
for further 20 minutes in KRBB supplemented with test stimuli.
Intracellular Ca2+ concentrations were determined using an
Accuri 6 flow cytometer (Accuri, Ann Arbor, MI, USA). Fluo-4
AM dye was excited by a solid-state blue laser (488 nm), 50000
events per sample were acquired at a slow flow rate (14 ml/min,
10 mm core) and the fluorescent emissions were detected at 530/
30 band pass filter (FL1). Data were acquired and analysed with
BD Accuri CFlowH software and results are presented as
percentage of control (KRBB with no additional stimuli).
Enzymatic determinations of metabolites. D-glucose
consumption, L-alanine consumption and L-lactate production
assays were carried out in 24 well plates (1:5|105 cells per ml).
After starvation and stimulation as described previously, aliquots
of KRBB used to stimulate the cells were taken for analysis at
0 min and 20 min, centrifuged at 400 g for 5 min at 4uC.
D-Glucose and L-Alanine consumption were determined using
quantitative enzymatic colorimetric assays, LiquiColor (Stanbio,
Boerne, TX, USA) and (BioVision, Miltipitas California, USA),
respectively and YSI 7100 Multiparameter Bioanalytical System
(Life Sciences, Fleet, UK). L-lactate production was measured
using a lactate oxidase based assay kit supplied by BioVision.
Analogously to insulin secretion assays, cell proteins were
incubated for 1 h with 150 ml of 1 X RIPA lysis reagent. Cells
lysates were then removed to fresh ice-cold micro-centrifuge tubes
and centrifuged at 14000 g for 15 min at 4uC. The supernatant
fraction was transferred to a fresh tube and stored at 220uC for
later analysis.
For L-glutamate determination, BRIN-BD11 cells were seeded
in a T175cm2 flask (2.06107 cells), starved and stimulated as
described previously. Subsequently, supernatant was removed and
discarded, cells were washed twice with ice-cold PBS, lysed and
total intracellular L-glutamate was determined according to the
manufacturer’s instructions using a colorimetric method (BioVi-
sion). An aliquot of lysates was stored at 280uC for later protein
determination.
Protein determination. Cellular protein content was quan-
tified using a BCA (bicinchoninic acid) protein assay kit (Pierce,
Rockford, IL, USA; kit no.23225), which utilizes a modification of
the Biuret reaction.
Cell size measurement
BRIN-BD11 cell size was determined by using two independent
approaches: (i) an indirect computer-based approach and (ii) direct
measurement in suspension.
(i) BRIN-BD11 cells were washed with PBS twice, trypsinized,
and removed in KRBB supplemented with 11.1 mmol/l D-
glucose and 0.005% DMSO-dissolved neutral red. BRIN-
BD11 cells were seeded at low density (1:0x104 per ml) on a
haemocytometer and allowed to adhere for 6 hours.
Subsequently, BRIN-BD11 cells were washed thoroughly
with PBS and high-power images (400 X magnification) were
obtained using a BX51 Olympus microscope (Olympus Life
Science Microscopes, Munich, Germany) and an Olympus
DP71 camera. Subsequently, images were imported in
MATLAB, processed (threshold and thinning) and cell size
was quantified by proportion between pixel numbers and
known dimension of the haemocytometer square.
(ii) BRIN-BD11 were detached by trypsinization, re-suspended
in complete media and removed into an Eppendorf at low
density (1:0x104 per ml) and subsequently their average
diameter was measured with a 60 mm scepter sensor
(catalogue number: PHCC60050, Millipore) mounted on
an impedance-based handheld automated cell counter
(ScepterTM 2.0, Millipore). Data were captured, manually
gated to exclude cell debris and analysed using the ScepterTM
Software Pro.
Statistical analysis
The results are presented as mean 6 SD (standard deviation).
Groups of data were compared using an unpaired Student’s t test
or one-way ANOVA, where appropriate. The level of significance
was set at P ,0.05.
Mathematical Modelling
We considered the following mathematical models focussing on:
1. L-alanine trigger of insulin secretion and how it enhances GSIS
through stimulation of oxidative metabolism;
2. The effect of direct membrane depolarization caused by L-
alanine / Na+-co-transport on triggering Ca2+ influx.
We separated the insulin secretion pathway into two main
modules: (i) core metabolic processes leading to ATP production
with either D-glucose and/or L-alanine as input (Figure 1. A) and
(ii) electrophysiological downstream events with metabolism-
derived ATP as input and Ca2+ influx as output (Figure 1. B).
The model incorporates the salient features of metabolic
processes and electrophysiology and their interactions without
explicitly modelling insulin secretion.
Both models were implemented, analysed and numerically
simulated in MATLAB using the built in solver ode15s.
Each model is described in detail separately below.
Core metabolic processes model. The essential compo-
nents of energy metabolism responsible for ATP production
following D-glucose and/or L-alanine input are schematized in
Figure 1. A.
We used a simple core metabolic model that includes glycolysis,
TCA cycle, L-alanine-related reactions, respiratory chain and
ATP synthesis machinery based on previous work by Nielsen [33]
for the glycolytic pathway and Mazat [46] for the mitochondrial
metabolism.
Enzymatic reactions are modelled using either mass action or
Michaelis-Menten kinetics and they are based on the original
studies [33,46] and adopted with minor modifications to represent
pancreatic b-cells.
Five additional reactions (solid blue lines in Figure 1. A) were
included in order to account for metabolism of L-alanine:
Glucose and Alanine Sensing in Pancreatic b-Cells








For simplicity, L-alanine-specific reactions are modelled as
reversible mass-action kinetics as in [46]:











Where kf represents the rate of the forward reaction, Keq the
equilibrium constant of the reaction whereas Zeq, Weq and Xeq,
Yeq are the equilibrium concentrations of products and reactants,
respectively.
Only one compartment is taken into account: cytosolic species
are instantaneously carried across the mitochondrial membrane
and their relative transporters are assumed to work in a region far
from saturation.
The model describes the dynamics of 18 state variables for the
glucose GLC, fructose 6-phosphate F6P, fructose 1,6-phosphate
FBP, glyceraldehyde 3-phosphate GAP, 1,3-biphosphoglycerate
DPG, phosphoenol pyruvate PEP, pyruvate PYR, L-lactate
LAC, acetyl co-enzyme A AcCoA, oxaloacetate OAA, citrate
CIT , a-ketoglutarate a{KG, L-glutamate GLU , L-aspartate
ASP, L-alanine ALA and the mitochondrial membrane potential



























































The complete list of the reactions included in the model and the
corresponding rate equations (27–51) can be found in Table 2
whereas initial conditions are enumerated in the first section of
Table S1 along with references to the original studies.
Calcium handling model
We are interested in computing whether an additional Na+ influx
brought about by L-alanine co-transport can significantly increase
the mean intracellular Ca2+ concentration at the steady state,
possibly accounting for a substantial raise in insulin secretion.
Membrane processes in b-cell are modelled according to the
Hodgkin-Huxley theory of membrane electrical activity in which
the rate of change of the plasma membrane potential V is given by
the current balance equation (52), [43]:
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Where Cmis the membrane capacitance and Iyiis the ionic current












With gyi the cell conductance, Vy is the reversal Nernst
equilibrium potential, R the gas constant, T the absolute
temperature, zy the ionic valence and y the concentration of the
ion on the respective side of the plasma membrane [43].
Our model is based on the work of Fridlyand [43] and uses ATP
derived from metabolism as input, as shown in Figure 1. B. The
original model includes equations for the Endoplasmatic Reticulum
(ER) Ca2+ sequestration events that have been reported in literature
and are believed to modulate the burst mechanism. However, since
electrophysiological events in b-cells are primarily driven by the
plasma membrane oscillator and to date there are no data indicating
that Na+ co-transport might affect ER Ca2+ stores or the
sarco(endo)plasmic reticulum Ca2+ ATPase pumping rate, ER
equations are not included in our model. Therefore, only one
compartment was taken into account: we did not distinguish upon
Ca2+ located in the cytosol or in the intracellular stores since our
experimental data quantified only the total intracellular Ca2+
content. The model assumes that the extracellular space is
constituted by a large volume, so that extracellular Ca2z
 
,
Naz½  and Kz½  are treated as a thermodynamic bath and can
be considered constant. Extracellular concentrations of Ca2+, Na+
and K+ are taken from [43] and their values are in good agreement
with the composition of KRBB used for the experimental work.
Pancreatic b-cells are characterised by a range of different
arrays of channels, however we only included the ones that are
most relevant to our object of investigation. In particular, a
delayed rectifying K+ current (IKzdr), K
+ ATP-dependent current
(IKzATP), K
+ Ca2+-activated current (IKzCa2z ), Ca
2+ plasma
membrane pump (ICa2zPump), Ca
2+ uniporter (voltage-dependent)
current (ICa2z ), Na
+ voltage-gated current (INaz ), Na
+/K+ pump
current (INazKz ), Na+/Ca
2+ exchanger current (INazCa2z ) were
included in this model. The mathematical formulations of these
currents and Nernst potential equations (55–69) were adopted
without major modifications from [43] and are listed in Table 3.
In order to account for L-alanine/Na+-co-transport, we intro-
duced an additional Na+ current to model the increase in
intracellular Na+ concentration that accompanies L-alanine uptake.
Although the detailed mechanism of L-alanine / Na+ symport is
not currently known, a study carried out on BRIN-BD11 has
provided evidence that the co-transport occurs through a Na+
tetrodotoxin (TTX)-insensitive channel [17]. Extracellular Na+
concentration is not the limiting factor for the transport as its level
is one order of magnitude higher than the corresponding
intracellular value. We model the Na+ current (INazAla) due to
L-alanine/Na+ co-transport by re-adapting an expression previ-
ously used to model an inward Na+ current through a TTX-
insensitive channel [39,61]. We then use the constant kNazAla as
an adjustable parameter to modulate the current flowing through












A V{VNazð Þ ð69Þ
The dynamic changes in intracellular concentrations of Naz
and Ca2z are explicitly modelled as well as the membrane
potential (V ), a voltage-dependent gating variable (w) and
intracellular ATP concentration. The resulting system of differ-






























































Initial conditions are listed in the first section of Table S2.
Parameter Values. Where possible the parameters used in the
model come directly from the literature, are extrapolated from the
literature, are re-calculated from other published models or are fitted
to the experimental data described herein. The full list of parameters
and their values are given in Table S1 for the core metabolic
processes model and in Table S2 for the Ca2+ handling model.
Supporting Information
Table S1 Mathematical model of core metabolic pro-
cesses in pancreatic b-cells: initial conditions and
standard parameters list.
(PDF)
Table S2 Mathematical model of Ca2+ handling in
pancreatic b-cells: initial conditions and standard pa-
rameters list.
(PDF)
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